Angiogenesis 2022 – Intravitreal Hydrogel-Based Axitinib Implant (OTX-TKI) for the Treatment of Neovascular AMD: Phase I Trial Data
Avni P. Finn MD, MBA Assistant Professor of Ophthalmology Vanderbilt Eye Institute, Nashville, TN Dr. Andrew Moshfeghi from the University of Southern California Roski Eye Institute presented an update on…